Preoperative Statin Therapy and Renal Outcomes After Cardiac Surgery: A Meta-analysis and Meta-regression of 59,771 Patients

Canadian Journal of Cardiology

Volumn 31, Issue 8, 2015, Pages 1051-1060

  Wang, Jiayang ^a   Gu, Chengxiong ^a   Gao, Mingxin ^a   Yu, Wenyuan ^a   Yu, Yang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE KIDNEY FAILURE; CORONARY ARTERY BYPASS GRAFT; HEART SURGERY; HUMAN; INCIDENCE; KIDNEY DISEASE; META ANALYSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; REVIEW; SYSTEMATIC REVIEW; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; HEART DISEASES; POSTOPERATIVE COMPLICATIONS; PROCEDURES;

ACUTE KIDNEY INJURY; CARDIAC SURGICAL PROCEDURES; HEART DISEASES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE;

EID: 84937734258     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2015.02.034     Document Type: Review

References (52)

1. Chertow G.M., Levy E.M., Hammermeister K.E., et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998, 104:343-348.
2. Ghotkar S.V., Grayson A.D., Fabri B.M., et al. Preoperative calculation of risk for prolonged intensive care unit stay following coronary artery bypass grafting. J Cardiothorac Surg 2006, 1:14.
3. Bove T., Landoni G., Calabro M.G., et al. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial. Circulation 2005, 111:3230-3235.
4. Burns K.E., Chu M.W., Novick R.J., et al. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing CABG surgery: a randomized controlled trial. JAMA 2005, 294:342-350.
5. Haase M., Haase-Fielitz A., Bagshaw S.M., et al. Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients. Crit Care Med 2007, 35:1324-1331.
6. Mentzer R.M., Oz M.C., Sladen R.N., et al. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: the NAPA Trial. J Am Coll Cardiol 2007, 49:716-726.
7. Knatterud G.L., Rosenberg Y., Campeau L., et al. Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators. Circulation 2000, 102:157-165.
8. Singh I., Rajagopalan S., Srinivasan A., et al. Preoperative statin therapy is associated with lower requirement of renal replacement therapy in patients undergoing cardiac surgery: a meta-analysis of observational studies. Interact Cardiovasc Thorac Surg 2013, 17:345-352.
9. Kuhn E.W., Liakopoulos O.J., Stange S., et al. Preoperative statin therapy in cardiac surgery: a meta-analysis of 90,000 patients. Eur J Cardiothorac Surg 2014, 45:17-26. discussion 26.
10. Layton J.B., Kshirsagar A.V., Simpson R.J., et al. Effect of statin use on acute kidney injury risk following coronary artery bypass grafting. Am J Cardiol 2013, 111:823-828.
11. Brunelli S.M., Waikar S.S., Bateman B.T., et al. Preoperative statin use and postoperative acute kidney injury. Am J Med 2012, 125:1195-1204.e3.
12. Bellomo R., Ronco C., Kellum J.A., et al. Acute renal failure - definition, outcome measures, animal models,fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8:R204-R212.
13. Mehta R.L., Kellum J.A., Shah S.V., et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11:R31.
14. Moher D., Liberati A., Tetzlaff J., et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. Int J Surg 2010, 8:336-341.
15. Moher D., Cook D.J., Eastwood S., et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999, 354:1896-1900.
16. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
17. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39(suppl 1):S1-S266. National Kidney Foundation.
18. Ortiz A., Covic A., Fliser D., et al. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet 2014, 383:1831-1843.
19. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
20. Christenson J.T. Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. Eur J Cardiothorac Surg 1999, 15:394-399. [discussion: 9-400].
21. Pan W., Pintar T., Anton J., et al. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 2004, 110(suppl 1):II45-II49.
22. Chello M., Patti G., Candura D., et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med 2006, 34:660-667.
23. Tabata M., Khalpey Z., Pirundini P.A., et al. Renoprotective effect of preoperative statins in coronary artery bypass grafting. Am J Cardiol 2007, 100:442-444.
24. Thielmann M., Neuhauser M., Marr A., et al. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery. J Thorac Cardiovasc Surg 2007, 134:1143-1149.
25. Mannacio V.A., Iorio D., De Amicis V., et al. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. J Thorac Cardiovasc Surg 2008, 136:1541-1548.
26. Fedoruk L.M., Wang H., Conaway M.R., et al. Statin therapy improves outcomes after valvular heart surgery. Ann Thorac Surg 2008, 85:1521-1525. [discussion 5-6].
27. Subramaniam K., Koch C.G., Bashour A., et al. Preoperative statin intake and morbid events after isolated coronary artery bypass grafting. J Clin Anesth 2008, 20:4-11.
28. Huffmyer J.L., Mauermann W.J., Thiele R.H., et al. Preoperative statin administration is associated with lower mortality and decreased need for postoperative hemodialysis in patients undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2009, 23:468-473.
29. Miceli A., Fino C., Fiorani B., et al. Effects of preoperative statin treatment on the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Ann Thorac Surg 2009, 87:1853-1858.
30. Martinez-Comendador J.M., Alvarez J.R., Mosquera I., et al. Preoperative statin treatment reduces systemic inflammatory response and myocardial damage in cardiac surgery. Eur J Cardiothorac Surg 2009, 36:998-1005.
31. Song Y., Kwak Y.L., Choi Y.S., et al. Effect of preoperative statin therapy on myocardial protection and morbidity endpoints following off-pump coronary bypass surgery in patients with elevated C-reactive protein level. Korean J Anesthesiol 2010, 58:136-141.
32. Gan H.L., Zhang J.Q., Bo P., et al. Statins decrease adverse outcomes in coronary artery bypass for extensive coronary artery disease as well as left main coronary stenosis. Cardiovasc Ther 2010, 28:70-79.
33. Argalious M., Xu M., Sun Z., et al. Preoperative statin therapy is not associated with a reduced incidence of postoperative acute kidney injury after cardiac surgery. Anesth Analg 2010, 111:324-330.
34. Spadaccio C., Pollari F., Casacalenda A., et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. J Cardiovasc Pharmacol 2010, 55:30-38.
35. Billings F.T., Pretorius M., Siew E.D., et al. Early postoperative statin therapy is associated with a lower incidence of acute kidney injury after cardiac surgery. J Cardiothorac Vasc Anesth 2010, 24:913-920.
36. Virani S.S., Nambi V., Polsani V.R., et al. Preoperative statin therapy decreases risk of postoperative renal insufficiency. Cardiovasc Ther 2010, 28:80-86.
37. Allou N., Augustin P., Dufour G., et al. Preoperative statin treatment is associated with reduced postoperative mortality after isolated cardiac valve surgery in high-risk patients. J Cardiothorac Vasc Anesth 2010, 24:921-926.
38. Bolesta S., Uhrin L.M., Guzek J.R. Preoperative statins and acute kidney injury after cardiac surgery: utilization of a consensus definition of acute kidney injury. Ann Pharmacother 2011, 45:23-30.
39. Mithani S., Kuskowski M., Slinin Y., et al. Dose-dependent effect of statins on the incidence of acute kidney injury after cardiac surgery. Ann Thorac Surg 2011, 91:520-525.
40. Presta P., Rubino A.S., Lucisano G., et al. Preoperative statins improve recovery of renal function but not by an anti-inflammatory effect: observational study in 69 elderly patients undergoing cardiac surgery. Int Urol Nephrol 2011, 43:601-609.
41. Prowle J.R., Calzavacca P., Licari E., et al. Pilot double-blind, randomized controlled trial of short-term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology 2012, 17:215-224.
42. Liakopoulos O.J., Choi Y.H., Haldenwang P.L., et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients. Eur Heart J 2008, 29:1548-1559.
43. Mehta R.L. Continuous renal replacement therapies in the acute renal failure setting: current concepts. Adv Ren Replace Ther 1997, 4:81-92.
44. Kumar V.A., Craig M., Depner T.A., et al. Extended daily dialysis: a new approach to renal replacement for acute renal failure in the intensive care unit. Am J Kidney Dis 2000, 36:294-300.
45. Dasta J.F., Kane-Gill S.L., Durtschi A.J., Pathak D.S., Kellum J.A. Costs and outcomes of acute kidney injury (AKI) following cardiac surgery. Nephrol Dial Transplant 2008, 23:1970-1974.
46. Molnar A.O., Parikh C.R., Coca S.G., et al. Association between preoperative statin use and acute kidney injury biomarkers in cardiac surgical procedures. Ann Thorac Surg 2014, 97:2081-2087.
47. Mangano C.M., Diamondstone L.S., Ramsay J.G., et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 1998, 128:194-203.
48. Windecker S., Kolh P., Alfonso F., et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014, 35:2541-2619.
49. Le Manach Y., Coriat P., Collard C.D., et al. Statin therapy within the perioperative period. Anesthesiology 2008, 108:1141-1146.
50. Yao H.W., Mao L.G., Zhu J.P. Protective effects of pravastatin in murine lipopolysaccharide-induced acute lung injury. Clin Exp Pharmacol Physiol 2006, 33:793-797.
51. Patti G., Pasceri V., Colonna G., et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. J Am Coll Cardiol 2007, 49:1272-1278.
52. Egger M., Schneider M., Davey Smith G. Spurious precision? Meta-analysis of observational studies. BMJ 1998, 316:140-144.